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Dysregulation of the biosynthesis of cholesterol and other lipids has been
implicated in many neurological diseases, including Parkinson’s disease.
Misfolding of α-synuclein (α-Syn), the main actor in Parkinson’s disease, is
associated with changes in a lipid environment. However, the exact molecu-
lar mechanisms underlying cholesterol effect on α-Syn binding to lipids as
well as α-Syn oligomerization and fibrillation remain elusive, as does the
relative importance of cholesterol compared to other factors. We probed
the interactions and fibrillation behaviour of α-Syn using styrene–maleic
acid nanodiscs, containing zwitterionic and anionic lipid model systems
with and without cholesterol. Surface plasmon resonance and thioflavin T
fluorescence assays were employed to monitor α-Syn binding, as well as fib-
rillation in the absence and presence of membrane models. 1H-15N-corre-
lated NMR was used to monitor the fold of α-Syn in response to nanodisc
binding, determining individual residue apparent affinities for the nanodisc-
contained bilayers. The addition of cholesterol inhibited α-Syn interaction
with lipid bilayers and, however, significantly promoted α-Syn fibrillation,
with a more than a 20-fold reduction of lag times before fibrillation onset.
When α-Syn bilayer interactions were analysed at an individual residue
level by solution-state NMR, we observed two different effects of choles-
terol. In nanodiscs made of DOPC, the addition of cholesterol modulated
the NAC part of α-Syn, leading to stronger interaction of this region with
the lipid bilayer. In contrast, in the nanodiscs comprising DOPC, DOPE
and DOPG, the NAC part was mostly unaffected by the presence of
cholesterol, while the binding of the N and the C termini was both inhib-
ited.
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Introduction
Parkinson’s disease (PD) is a protein misfolding dis-
ease associated with a conversion of α-Syn from its
soluble state into fibrillar aggregates. During this con-
version, α-Syn forms soluble, toxic oligomers that are
implicated in the dopaminergic neuron cell death asso-
ciated with clinical manifestations of PD [1]. The exact
function of native α-Syn is not fully understood, nor
are the driving forces governing its misfolding,
oligomerization and fibrillation, including the specific
roles of individual residues within the protein. It has
been proposed that α-Syn plays a role in synaptic plas-
ticity allowing ‘kiss-and-run’ neurotransmitter release,
where the protein assists vesicles containing the neuro-
transmitters to fuse with the synaptic membrane tran-
siently so that it can deliver its cargo before
disengaging [2]. Unfortunately, the role of the interac-
tion between α-Syn and lipid bilayers is unclear as a
consistent pattern of behaviour has not been observed
(review [3]). Research, including relatively recent and
comprehensive work by Viennet et al. [4], indicates
that two important membrane general characteristics
are affecting the interaction between α-Syn and lipid
membrane: its net charge and physical state. A higher
abundance of anionic lipids, such as phosphatidylser-
ine (PS) or phosphatidylglycerol (PG), leads to a
higher affinity of α-Syn and a slower aggregation [4,5].
Likewise, pronounced membrane curvature and smal-
ler lipid head group size seem to promote the interac-
tion of α-Syn [4,6,7]. Protein modifications may also
be an important factor in the PD pathology through
its relationship between α-Syn and the membrane [8];
acetylation at the N-terminal promotes binding while
leaving aggregation behaviour largely unchanged
[4,9,10]. With this is in mind, there is a notable lack of
knowledge regarding how cholesterol, the most abun-
dant mammalian component of the plasma membrane
(PM), affects α-Syn.
Cholesterol constitutes about 50% of the mass of
PMs in mammals and has a considerable effect on its
physical properties, including its fluidity and perme-
ability [11,12]. When residing in the bilayer, cholesterol
is only marginally accessible to the solvent or periph-
eral protein interaction as it is primarily its -OH group
that is exposed [13]. However, cholesterol has promi-
nent effects on how other lipids are organized, and
may in this way confer larger effects than its small
exposure would initially suggest. Cholesterol is particu-
larly abundant in the brain, and its dysregulation has
been linked to several neurodegenerative diseases,
including Alzheimer’s disease (AD) [14,15], Hunting-
ton’s disease [16] and Niemann–Pick disease type C
[17,18]. Recent evidence suggests that cholesterol is
more abundant in the inner monolayer of the synaptic
membrane, where α-Syn makes contact with the PM
as part of its function [19]. It has also been observed
that the cholesterol abundance in the PM of neurons
decreases with age, which in turn could drive or confer
vulnerability towards neurodegeneration [20]. This age-
dependent loss of cholesterol from the PM seems to
affect the release of neurotransmitters by hindering the
fusion of presynaptic vesicles [21]. However, the clini-
cal connection between PD and cholesterol abundance
and distribution remains unclear. There is evidence
that higher level of serum cholesterol is associated with
a higher risk of PD [22] and a decrease in the risk of
PD [23], or is not associated with PD at all [3,24].
There are also contradictory results regarding the
interaction of α-Syn and cholesterol at the molecular
level. A cholesterol-binding site in the nonamyloid
component (NAC) of α-Syn has been reported, and
that through this site, cholesterol is essential for the
formation of cytotoxic ‘amyloid pores’ [25–27]. How-
ever, recent work has shown that the presence of
cholesterol inhibits the binding of α-Syn to membranes
comprising either zwitterionic or anionic lipids [28,29].
The apparent discrepancy in affinity between α-Syn
and cholesterol, and the interaction of α-Syn and lipid
head groups have, to our knowledge, not been
explained adequately. Despite contradictory and
incomplete evidence, current knowledge strongly sug-
gests a role for cholesterol in both the normal function
and misfolding of α-Syn.
The investigation of reversible protein–membrane
interactions often relies on lipid vesicles or supported
lipid bilayers [30]. However, such lipid assemblies limit
the interpretation and application of many methods
including solution-state NMR, steady-state affinity
measurements and fibrillation studies [31]. Nanodiscs,
consisting of circular patches of lipid bilayer sur-
rounded by a polymer belt, have emerged as an alter-
native to vesicles and have been successfully used in
structural studies of membrane proteins and anchored
peripheral proteins [31,32]. As they can be prepared
with narrow size distributions, well-defined lipid com-
positions and are stable in solution, they are promising
tools for studying reversible protein–lipid interactions
[32,33]. In this study, we use styrene–maleic acid
(SMA) nanodiscs as the primary membrane model sys-
tem for our studies. These nanodiscs have properties
similar to those that are prepared using a protein belt
to scaffold the lipids, but allow detergent-free seques-
tration of lipids directly from a vesicle or even native
membranes [32]. Recently, protein-scaffolded nan-
odiscs were used to investigate the role of charge and
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fluidity on α-Syn binding and aggregation [4]. The
study notes that while high-resolution solution-state
NMR is made possible by nanodiscs and yields
sequence-specific binding information, it does not
allow direct detection of α-Syn membrane-bound state
[4]. However, their comprehensive work allowed them
to propose a model for α-Syn membrane interaction
and its effect on fibrillation that focused on the protein
competing for favourable binding sites on fluid patches
with net negative charge. In their model, increased fib-
rillation occurred when α-Syn competed for the most
favourable binding sites, bringing exposed NAC
regions together [4]. Given the importance of choles-
terol for α-Syn binding and the implication of the
NAC region, further detailed investigation focusing on
the effect of cholesterol is warranted.
We hypothesize that there is an interplay between
cholesterol abundance of the membrane and the rever-
sible and dynamic α-Syn binding, the protein confor-
mational response, and ultimately the protein
oligomerization and fibrillation outcome. We further
propose that the changes in the protein conformation
are primarily driven by an interaction between the
NAC region and cholesterol-induced ordering of the
bilayer. We present a comparative lipid-dependent
binding and fibrillation study of recombinant α-Syn
using SMA lipid nanodiscs consisting of zwitterionic
DOPC and a membrane model containing DOPC, PE
and PG in a 4 : 3 : 1 ratio. Each model was also pre-
pared with 30% (w/w) cholesterol. As an indicator for
how the presence of nanodiscs affects α-Syn at a
detailed level, we have determined residue-specific
apparent binding constants for ~ 40% of residues
evenly distributed within the α-Syn sequence using
increasing widths of 1H-15N HSQC cross-peaks and
formalism adapted from Shortridge et al. [34]. Lastly,
we monitored the effect of cholesterol in lipid nan-
odiscs on oligomerization rates of α-Syn by using thio-
flavin T (ThT) and a novel tetraphenylethene tethered
with triphenylphosphonium (TPE-TPP) fluorescence
marker [35], potentially allowing earlier detection of
the onset of fibrillation than the standard ThT
approach.
Results
Binding of α-Syn monomers to lipid vesicles is
inhibited by cholesterol
Vesicles systems are the material basis for SMA nan-
odiscs [32] and are commonly used membrane model
systems in their own right. A zwitterionic vesicle model
with a mean diameter of ~ 100 nm was prepared using
DOPC alone, as well as a more complex anionic model
using DOPC : PE : PG in a 4 : 3 : 1 molar ratio. The
structures of lipids used and a representative vesicle
diameter distribution, as determined by DLS, are
shown in Fig. S1. Each model was also prepared with
30% (w/w) cholesterol, yielding a total of four differ-
ent lipid compositions. Representative surface plasmon
resonance (SPR) plots of α-Syn binding to these lipid
models in room temperature are shown in Fig. 1A–D.
The steady-state dissociation equilibrium constants,
KD, of α-Syn were estimated using Eqn (1) (Fig. 1D).
The dissociation constant for DOPC mixtures was
approximately 7.2 times higher (1072  137 nM) than
that for DOPC : PE : PG vesicles (148  36 nM)
[36–39]. Vesicles containing 30% (w/w) cholesterol
showed an almost twofold increase in the KD
(2138  322 nM for DOPC and 273  36 nM for
DOPC : PE : PG vesicles). These values indicate that
cholesterol addition to these overall fluid systems has a
general inhibitory effect on binding, as the KD was
increased in both lipid models. We then wanted to
explore how this observation translated into changes
in α-Syn fold and aggregation behaviour. However,
the bulky and quasi-stable vesicle models are not suit-
able for fibrillation studies that often span days [40],
and the use of vesicles is not suitable for NMR studies
directly monitoring individual residues [41].
Preparation and characterization of SMA
nanodiscs
We therefore prepared nanodiscs from 100-nm vesicles
of the same compositions as used for the SPR affinity
measures. This was done by adding SMA to 1% w/v
and overnight incubation followed by size-exclusion
chromatography (SEC) purification. Although the
presence of cholesterol and PE in the vesicles inhibited
proper nanodisc formation, we were able to optimize
the process as described in Fig. 2A,B, Tables S1, S2
and Fig. S1. Nanodisc zeta potential and dimensions
as determined by DLS are summarized in Fig. 2A,B.
Inclusion of cholesterol into the nanodiscs was verified
using LC-MS/MS (Fig. S3).
Given the importance of phase behaviour in α-Syn
interaction and aggregation behaviour [4,9,37], we also
investigated the nanodiscs and vesicles comparatively
using laurdan, a lipid-sensitive fluorescence probe.
Laurdan is a fluorescent reporter molecule that locates
itself at the hydrophobic–hydrophilic interface of a
membrane and enables investigators to indirectly
observe lipid packing, a property that is relatable to
fluidity [42,43]. Both laurdan excitation and emission
spectra are affected by the polarity of the surrounding
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environment and by the water dipolar relaxation
[44,45]. Excitation spectra (Fig. 2C,D) for both lipid
nanodiscs and lipid vesicles contain two peaks, at 350
and 390 nm. The peak at 350 nm reports on the liquid
crystalline phase of the lipid bilayer, while the peak at
390 nm indicates a denser packing of lipids around
laurdan and is associated with the presence of a gel
phase. Overall, however, the results show that our
bilayers are predominantly fluid in the absence of
cholesterol. This is also confirmed by the calculated
generalized polarization functions, where a low ExGP
and the presence of a negative slope as the wavelength
increases are indicative of a fluid phase (Fig. 2E,F)
[46,47]. Upon addition of cholesterol, there is an
increase in the overall ExGP function in all cases, indi-
cating an ordering of the bilayer. This response is not
as large for nanodiscs, however, suggesting that these
lipids remain more solvent-accessible than their vesicle
counterparts.
The presence of cholesterol in the lipid nanodiscs
influences both lag time and rate of fibrillation of
α-Syn
We then used the lipid nanodiscs to explore how the
different bilayer models affected the fibrillation rate of
α-Syn. ThT and TPE-TPP fluorescence assays were
















Fig. 1. Monomeric α-Syn binding to vesicles
is inhibited by cholesterol. Representative
SPR plots of α-Syn interaction with
immobilized lipid layers of DOPC (A) and
mixtures of DOPC : PE : PG (4 : 3 : 1) (B),
without and with the addition of 30% (w/w)
cholesterol (C and D, respectively).
Equilibrium values are indicated with red
circles where the vertical lines intersect the
sensorgrams. Red line represents fitting
into Eqn (1). (E) Mean KD values for each
lipid group. Each value represents 3–5
replicates, and error bars depict standard
deviations.
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absence and in the presence of lipid nanodiscs at
37 °C. ThT is a fluorescence probe that is widely used
to characterize the aggregation of various amyloido-
genic peptides, also in the presence of lipid bilayers
[48–50]. In contrast, TPE-TPP is, to our knowledge,
untested as a fluorescence marker in the presence of
lipids. The compound is a structural ThT analogue
developed by Leung et al. [35]. It binds to fibrils by a
similar mechanism as ThT, but it is two orders of
magnitude more sensitive and therefore potentially an
earlier reporter of fibrillation [51].
We adopted a high-throughput technique, using
384-well plates and incubation time of up to 150 h
[52]. Briefly, we evaluated the experiment using cumu-
lative curve plots, where each well is annotated as
either positive or negative based on its fluorescence
signal [52]. The percentage of positive wells against
time is then plotted (Fig. 3A), and from this, the lag
time for each experimental condition can be read
directly. The lag time of α-Syn, 20 h, increased in the
presence of DOPC and DOPC : PE : PG lipid
nanodiscs to 50 and 60 h, respectively. However, with
cholesterol present in the lipid nanodiscs, the lag time
dropped to 3 and 2 h, respectively. We then evaluated
the experiment more in-depth, by fitting the fluores-
cence signals from each well independently to a two-
step Finke–Watzky model [53] (Eqn 2). From this
model, we obtained the tN (lag time, Eqn 3) and ν (fib-
rillation rate). The ratio of tN/tN control and ν/νcontrol is
presented in Fig. 3B,C.
Using the TPE-TPP fluorescence dye, we were able
to detect the early stages of fibrillation of α-Syn alone
(Fig. S4B). However, with the addition of lipid nan-
odiscs we observed a loss of fluorescence (Fig. S5).
This suggests the release of TPE-TPP from the cross-
β-sheets of α-Syn and its interaction with the lipid nan-
odiscs. TPE-TPP was therefore deemed unsuitable for
fibrillation studies in the presence of our model system
of choice, but did serve well as an early and sensitive
marker for fibrillation events. The results presented
below are therefore derived from ThT-based assays
only.





















































Fig. 2. Nanodiscs preparation and
characterization. (A) Table of lipid nanodiscs’
physical properties. Four compositions of
nanodiscs have been used: DOPC, DOPC
with 30% (w/w) cholesterol,
DOPC : PE : PG (4 : 3 : 1) and
DOPC : PE : PG with 30% (w/w)
cholesterol. Size and zeta potential were
measured using Nanosizer ZS. (B) DLS
measurement of prepared nanodiscs which
were purified by SEC. Both DOPC and
DOPC : PE : PG (4 : 3 : 1) nanodiscs
without cholesterol are smaller (mean sizes:
10 and 13 nm, respectively) than nanodiscs
containing 30% (w/w) cholesterol (32 and
29 nm, respectively). (C, D) Laurdan
excitation and emission spectra for lipid
nanodiscs and vesicles at 37 °C. Excitation
spectra (full line) were collected using a
fixed emission wavelength of 430 nm.
Emission spectra (dashed line) were
collected using a fixed excitation
wavelength of 390 nm. (E, F) Laurdan
excitation (ExGP) and emission (EmGP)
generalized polarization functions for lipid
nanodiscs and vesicles in 37 °C, calculated
using Eqns (S1) and (S2), respectively, from
Bagatolli et al. [46].
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The tN ratio (lag time ratio) is three times higher
when nanodiscs (without cholesterol) are present dur-
ing fibrillation (3.1  0.77 for α-Syn and DOPC,
3.5  0.84 for α-Syn and DOPC : PE : PG and
1.0  0.38 for α-Syn alone, t-test P < 0.01). How-
ever, the fibrillation rate ratio, ν, did not change sig-
nificantly (1.0  0.22 for α-Syn alone, 0.7  0.22 for
α-Syn and DOPC, and 1.0  0.05 for α-Syn and
DOPC : PE : PG). When cholesterol was present, the
tN ratio approached zero as the fluorescence started
to increase almost immediately after the addition of
lipid nanodiscs (−0.01  0.20 for α-Syn and DOPC
with 30% cholesterol and −0.03  0.03 for α-Syn
and DOPC : PE : PG with 30% cholesterol). More-
over, we observed a significant 14-fold increase in
the ν ratio in the presence of cholesterol compared
to the control (15  2.26 for α-Syn and DOPC with
30% cholesterol and 13  2.13 for α-Syn and
DOPC : PE : PG with 30% cholesterol, t-test,
P≪0:01).
We also monitored the morphology of α-Syn during
the lag phase of fibrillation kinetics using atomic force
microscopy (AFM) (Fig. 3D). For α-Syn incubated
alone, we did not find any fibrils, and only small gran-
ular deposits of α-Syn were observed by using both
10 × 10 µm and 2 × 2 µm scan sizes (Fig. 3D insets).
In α-Syn + DOPC sample, we can clearly observe the
DOPC nanodisc as spheres of 50–100 nm, larger than
the diameters in Table S1. Small deposits of α-Syn
alone were not visible at the background. In the
2 × 2 µm scan size, however, we observe what we
interpret as some aggregation of α-Syn around the
nanodiscs. The same situation, but also with choles-
terol present, shows a more diverse morphology, where
nanodiscs and α-Syn co-aggregate to a larger extent.
The 2 × 2 µm scan size in the inset shows an α-Syn
fibril. In the case of the negatively charged DOPC :
PE : PG nanodiscs with cholesterol, we observed a
mix of morphologies consistent of discs with associ-
ated α-Syn aggregates. The 2 x 2-µm inset shows fibril
morphologies, although the fibrils are shorter and
more diffuse than in the case of DOPC with choles-
terol.
Cholesterol affects the interaction of α-Syn and
lipid bilayer differently in DOPC and
DOPC : PE : PG lipid models
While our results clearly show that cholesterol affects
both binding and aggregation behaviour of α-Syn, it is
unclear how the protein itself is affected by the differ-
ent nanodisc membrane models. To explore the mech-
anism of α-Syn and cholesterol interaction at a more
detailed level, we proceeded with NMR studies to
determine which amino acids are affected in the pres-
ence of lipid nanodiscs. Lipid nanodiscs of the compo-
sitions described above were titrated into 15N-labelled
α-Syn, and HSQC fingerprints were acquired at 299K
to monitor changes in the chemical environment of
individual residues. Cross-peak assignments were
adapted from BMRB entry 6968 [54] and 25227 [55]
and verified using Cα and Cβ chemical shifts from stan-
dard triple-resonance experiments performed on a dou-
ble-labelled α-Syn sample. In agreement with other
studies [56–58], we did not observe any chemical shifts
of cross-peaks, which would represent a direct obser-
vation of changes in the chemical environment.
Instead, we observed line (peak) broadening which
grows beyond detection in the high concentrations of
lipid nanodiscs (Fig. 4A). These undetectable peaks,
sometimes called invisible states, are ascribed to chemi-
cal exchange broadening or efficient relaxation path-
ways related to molecular motions [56]. Free and lipid-
associated α-Syn in exchange between states,
intramolecular interaction in folding and intermolecu-
lar oligomerization may all cause line broadening and
loss of observable states. We evaluated these invisible
states as possible binding curves, using logic presented
by Shortridge et al. [34] for estimating protein/ligand
affinity. Between 77 (α-Syn and DOPC : PE : PG with
30% cholesterol) and 82 (α-Syn and DOPC) cross-
peaks and their individual line-broadening behaviour
in response to lipid nanodiscs were observed for each
lipid nanodisc model. Using the PINT software [59],
we deconvoluted peaks for each assigned amino acid
and calculated a residue-specific apparent KD (aKD)
based on Eqn (4) [34], which provides values biased
towards the lower limit of the actual, unknown KD [4].
From 48 (α-Syn and DOPC : PE : PG with 30%
cholesterol) to 67 (α-Syn and DOPC) cross-peaks had
good correlations with the model (r > 0.90, examples
shown in Fig. 4B, all extracted aKD values in Table
S4B).
In order to visualize the results, each residue-specific
aKD was then plotted as a function of lipid nanodisc
composition and its position in the α-Syn primary
sequence (Fig. 4C). High values of aKD (> 500 µM)
were observed in the C-terminal part of α-Syn in the
presence of all lipid models. The lowest aKD values
were observed for N-terminal part of α-Syn, suggesting
that this part of the molecule is essential for the bind-
ing to lipid bilayers. This is consistent with earlier
studies [4,60,61]. Overall, the heatmap suggests that
there are three distinct regions of α-Syn: the N-termi-
nal with high affinity for lipid membranes, the middle
NAC region with an intermediate affinity and the C-
6 The FEBS Journal (2020) ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
Lipid nanodiscs influence α-Syn oligomerization rates M. Jakubec et al.
terminal with low affinity. This division is expected, as
it fits well with a standard description of α-Syn struc-
ture [4,62,63]. Consistent with recent research [58,64],
most of the observable peaks in the C-terminal region
did not change in any way, suggesting most of the C-
terminal domain remains unperturbed in a random
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Fig. 3. Cholesterol promotes early
oligomerization. (A) The cumulative
distribution of ThT-positive wells. The
number of repeats for each case is 39 (α-
Syn only), 30 (DOPC), 33 (DOPC : PE : PG),
61 (DOPC with cholesterol) and 55
(DOPC : PE : PG with cholesterol). Each set
of repeats is generated from 3 independent
experiments. (B) Ratio of tN/tN control, which
represents lag time ratio (relative primary
nucleation rate). (C) Ratio of ν/νcontrol, which
represents the relative growth rate. (B, C)
Central mark of the box indicates median;
the top and bottom of the box indicate 25th
and 75th percentiles, respectively. The
whiskers extend to extreme data points;
outliers are indicated by red ‘+’ symbol. (D)
Representative AFM images of α-Syn in the
presence and absence of nanodiscs with
and without cholesterol. The lipid
composition of the nanodiscs used in each
case is indicated next to the figure panels.
The images are all acquired at 256 × 256 px
resolution during the lag phases of the ThT-
monitored fibrillation kinetics. Every sample
was prepared 3 times, and for each
preparation, 5 random areas were selected
for imaging. Each panel shows randomly
selected image of 10 μm × 10 μm size,
while the insets are of 2 × 2 μm size.
Vertical scales span from darkest to
brightest colour: α-Syn (2.6 nm, inset
4.0 nm), α-Syn + DOPC (16.5 nm, inset
19.8 nm), α-Syn DOPC with cholesterol
(6.6 nm, inset 3.4 nm) and α-
Syn + DOPC : PE : PG with cholesterol
(7.5 nm, inset 8.8 nm).
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Since the presence of cholesterol has such an impact
on both α-Syn binding and fibrillation rates, we
wanted to determine which parts of α-Syn were partic-
ularly affected. Cholesterol-induced changes in the
aKD values are therefore plotted in Fig. 5A,B and pro-
jected onto the PDB model (Fig. 5C). When choles-
terol is present in the lipid nanodiscs, we could see
two different types of interaction behaviour. For the
DOPC : PE : PG model, we observed a slight increase
of aKD in both the amphipathic and acidic region of
α-Syn, while the NAC region is mostly unaffected
(Fig. 5B). The aKD increase was most prominent in
the C-terminal region and in several N-terminal region
residues. This is in line with what was observed by
SPR (Fig. 1), where cholesterol seems to inhibit the
interaction of α-Syn and the anionic lipid bilayer. In
contrast, the trend for DOPC and cholesterol is
entirely different (Fig. 5A). When cholesterol was pre-
sent in DOPC lipid nanodiscs, we observed a decrease
in aKDs along almost the whole sequence of α-Syn.
This decrease was highest in the NAC region, which
suggests that this part was the key α-Syn segment in
binding DOPC bilayers affected by cholesterol. How-
ever, the overall increase in α-Syn aKDs for DOPC :
PE : PG nanodiscs containing cholesterol was smaller
than the overall decrease in aKDs for DOPC nanodiscs
containing this lipid. This suggests that the effect of
including smaller and charged head groups is higher
and more pronounced than the effect of cholesterol on
α-Syn binding to the lipids. It should also be noted at
this point that addition of cholesterol to nanodiscs
also increased their diameters to almost double
(Fig. 2), possibly creating more nucleation sites
through size effects alone.
Discussion
The interest in the role of lipid composition on α-Syn
function and dysfunction has prompted research with
a variety of membrane model systems [65]. Nanodiscs
comprising lipids with a variety of charges and acyl-
chain saturations have been used in recent α-Syn
research [4,66]. In the present study for the first time,
we have produced and studied the effect of choles-
terol-containing nanodiscs. Inclusion of cholesterol
and PE impaired disc formation, but this was over-
come by adjusting the SMA concentration and by hav-
ing SMA present at vesicle extrusion. SMA discs
consequently proved to be versatile model systems
with respect to the lipids that can be included in the
bilayer. For fibrillation experiments, the nanodiscs
removed reliance on unstable and insoluble vesicles,
allowing much longer experiments.
The presence of lipids with a net negative charge
has been established as a primary determinant for
reversible protein–membrane interactions in general
[67–70] and also for α-Syn [4,7,36]. Other membrane-
related factors reported in the literature are fluidity
[4,9] and packing defects [38]. Our study shows that
higher net charge and smaller head groups (from pure
DOPC to a mixture of DOPC : PE : PG (4 : 3 : 1))
lead to a substantial increase in affinity (Fig. 1), con-
sistent with earlier studies [36–39,71]. The nanodiscs
have a more negative zeta potential than the corre-
sponding vesicle except in the DOPC instance (Fig. 2),
suggestive of increased binding due to this factor. The
presence of cholesterol does not affect zeta potentials
much, again except for the DOPC vesicle case. In fact,
the substantial change (−18.7 mV for DOPC only to
−6.9 mV when cholesterol is present) in zeta potential
could account for much of the reduction in binding in
this particular case, in accordance with results in
Fig. 1E. While it has been reported that cholesterol
can promote the interaction between α-Syn oligomers
and zwitterionic PC and PE lipids prepared as vesicles
and sonicated lipid dispersions [72,73], we do not
observe this for our PE-containing system. This may
be due to the fact that our initial binding studies are
performed with monomeric α-Syn and that our model
systems are different, that is, not prepared with high
curvature and sonication. Aside from effects on parti-
cle zeta potential, cholesterol is well known to affect
an ordering of fluid bilayers [12,74,75], a property
highlighted by recent research as relevant for α-Syn
oligomerization behaviour [4,73]. In our study, the
SPR binding experiments revealed relatively low affin-
ity between monomeric α-Syn and DOPC vesicles,
while DOPC : PE : PG vesicles elicited strong binding
(steady-state KDs of 1.079 and 0.168 µM, respectively).
Corresponding bilayers containing cholesterol caused
an almost twofold increase of KD in both lipid models.
However, the KD for DOPC : PE : PG with 30%
cholesterol was still almost four times lower than that
for the DOPC membrane model. The laurdan fluores-
cence experiments confirmed an ordering of the bilayer
when cholesterol was included (Fig. 2C–F). The exper-
iments also suggested that the bilayers encased in nan-
odiscs had a more solvent-accessible lipid packing than
their vesicle counterparts. The tighter and more
ordered packing of lipids induced by cholesterol had a
negative impact on the α-Syn bilayer interaction,
although even with a cholesterol content of 30%, all
of our vesicle membrane model systems are expected
to be fluid and miscible at 310 K [74–76]. While the
changes in observed binding cannot then be directly
attributed to the presence of ordered phases, our
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findings are consistent with recent reports, finding that
bilayer fluidity is an essential driver for binding along-
side charge [4,72].
Nanodiscs allowed us to investigate the protein con-
formational response by NMR, but the problem with
protein states that are invisible to NMR remains due
to a combination of complex chemical exchange
between protein states and line-broadening effects due
to efficient relaxation [4,77]. The nanodiscs in combi-
nation with the stochastic approach adapted from
Afitska et al. [52], made it possible to investigate the
effect of membrane components on fibrillation rates
while avoiding experimental sensitivity to initial condi-
tions, that otherwise would be difficult to control for.
The onset of α-Syn fibrillation was delayed in the
presence of lipid nanodiscs lacking cholesterol (Fig. 3).
In the presence of both DOPC and DOPC : PE : PG
nanodiscs, there was almost a threefold increase in α-
Syn fibrillation lag time (Fig. 3B). This observation is
similar to other reports where α-Syn fibrillation is
delayed by the presence of lipids [36,37,52]. Moreover,
no significant changes in the fibrillation rate were
observed (Fig. 3C). This suggests that the lipids effec-
tively decrease the population of free α-Syn monomers,
leaving less protein available for oligomerization and
fibrillation. Surprisingly, this is also observed in the
presence of zwitterionic DOPC to which α-Syn has a
very low affinity. It seems that even this low affinity is
sufficient to almost double lag times for the onset of








































































Fig. 4. Site-specific interaction of α-Syn
with lipid nanodiscs with and without
cholesterol. (A) HSQC plots of 100 μM α-Syn
and DOPC nanodiscs. With increasing lipid
nanodisc concentrations (62.5, 125, 250 and
500 μM) from left to right, there is a
decrease in a number of observed α-Syn
peaks. (B) Example of fits for three amino
acids—V15, A53 and E131—with a
medium, high and low aKD (from left to
right). Each line represents different lipid
environments, legend in E131 inset. (C)
Heatmap of calculated aKD values for amino
acid residues of α-Syn in the presence of
lipid nanodiscs from Eqn (4). Only the
amino acids with r2 > 0.90 are shown.
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AFM images of DOPC nanodisc, where discs appear
to keep α-Syn aggregates from appearing on the back-
ground (Fig. 3D). The potential for using zwitterionic
small unilamellar vesicles to inhibit the onset of α-Syn
fibrillation and protect dopaminergic cells has recently
been reported by Aliakbari et al. [66]. It seems that α-
Syn engages in a dynamic exchange with PC and PE
membrane components that do not give rise to high-
affinity binding, but is nonetheless very important for




























Fig. 5. Cholesterol in noncharged nanodiscs
promotes site-specific α-Syn binding. (A, B)
Bar plot of aKD difference for samples with
and without cholesterol for DOPC (A) and
DOPC : PE : PG (B) lipid nanodiscs. Only
amino acids with r2 > 0.90 for both samples
are shown. The sequence is visually divided
into three parts of the α-Syn protein: the N-
terminal amphipathic region, the NAC
region and the C-terminal acidic tail (light
red, light green and light blue, from left to
right). (C) Representation of the estimated
difference of aKD values after the addition
of cholesterol. The representation was
prepared in PyMOL (Schrödinger, Inc.),
using PDB entry 1XQ8 as a template.
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The presence of cholesterol in the lipid nanodiscs
caused a significant promotion of α-Syn fibrillation
(Fig. 3). The lag times decreased almost to zero (Fig. 3
B) and fibrillation rate increased to more than 13 times
that of α-Syn alone (Fig. 3C). One possible explana-
tion for these dramatic changes is that lipid nanodiscs
containing cholesterol served as a seeding agent, inde-
pendently of other lipids present. Other reports on the
effect of cholesterol on α-Syn fibrillation are conflict-
ing, possibly because factors such as curvature, phase
behaviour or miscibility of the lipid mixes in use are
not comparable. Simple size effects may also play a
role. Addition of cholesterol doubles the average nan-
odisc sizes (Fig. 2). Some studies using lipid vesicles
did not observe any promotion of α-Syn fibrillation by
lipid vesicles containing cholesterol [28,66], while other
studies observed increased oligomerization in the pres-
ence of oxidized cholesterol metabolites [78] or
increased fibrillation and deposit formation in cell cul-
tures exposed to higher cholesterol concentrations [79].
The lipid nanodiscs used in our experiments are much
smaller (see Fig. 2A) than vesicles used in previous
experiments, and there is no bilayer curvature. Our
results are supportive of a planar bilayer being able to
promote, when cholesterol is present, colocalization
and co-orientation of α-Syn molecules in a spatially
restricted area. This effect of local enrichment of α-
Syn on membranes and molecular crowding has been
suggested as the mechanism of α-Syn fibrillation in live
cells [80]. However, it is still unclear whether choles-
terol plays a unique role in this, as evidence exists for
ordered, planar bilayers promoting α-Syn fibrillation
in the absence of cholesterol [4].
Using the approach of Shortridge et al. [34] it was
possible to determine aKD values for individual resi-
dues in the α-Syn primary sequence and in this way
gain some insight into how different membrane com-
ponents affect different parts of the protein. The aKD
values do not differentiate between the possible causes
of line broadening, but reflects the net effect the nan-
odiscs have on diminishing the protein signals. While
the approach yielded valuable information, we could
observe and fit only 48% of the amino acid sequence.
This number is reduced for samples containing 30%
cholesterol. The undetectable amino acid states suggest
that protein–lipid, protein–protein or intramolecular
exchange takes place on a timescale unfavourable for
NMR observation. Most of the lysines, which have a
strong electrostatic affinity for lipid head groups
[37,71], were not observed in the presence of lipids. In
fact, if we inspect amino acids which correspond to
undetectable peaks and where they appear in the
sequence (Fig. 4C), we find that most invisible states
are organized in nonperfect hexameric KTKEGV
repeats, which represent a small α-helical motif with
high affinity to lipid environment [37,62,81,82]. The
fact that the presence of cholesterol causes more α-Syn
residues in these repeats to become undetectable sug-
gests that these are affected by the presence of choles-
terol. This is particularly apparent in the N-terminal
region and NAC region, where we observed a longer
stretch of invisible peaks in the T72-V82 region. This
stretch coincides with the ending of the NAC core,
which has been proposed to function as a sensor of
the state of the lipid bilayer [56] and which participates
in the formation of β-sheets during oligomerization
[83]. Notably, this invisible stretch is extended when
the cholesterol is present, particularly in the presence
of DOPC : PE : PG with 30% cholesterol nanodiscs,
indicating that the NAC region is affected by the
ordering effect that cholesterol has upon the bilayer.
We also observed several disappearing peaks in the C-
terminal (especially in the interval G132-D135) which
is, generally, regarded as nonreactive towards lipids
but protective against aggregation [84,85]. This sug-
gests a chaperone-like activity for this region, main-
taining at least some protein interaction with the
solvent rather than allowing it to nucleate at the mem-
brane or other potential seeding sites, as has been sug-
gested by other authors [52,85]. The influence of
cholesterol on this part of the protein would interfere
with the moderating effect of the C-terminal, con-
tributing to accelerated nucleation of α-Syn. Interest-
ingly, it has recently been shown that the C-terminal
helps to modulate α-Syn membrane interaction and its
localization at the presynaptic terminal by binding to
Ca2+ [64]. Moreover, natively occurring C-terminally
truncated α-Syn is associated with increased fibrilla-
tion, a phenomenon that was further enhanced, if
known disease mutants were present in the fibrillation
assays [85].
In our study, we have shown that the presence of
cholesterol has an overall inhibitory effect on α-Syn to
lipid vesicles. However, we have also observed that
lipid nanodiscs containing cholesterol can act as a
strong promoter of α-Syn fibrillation. Both inhibition
of α-Syn binding to vesicles and promotion of α-Syn
fibrillation by lipid nanodiscs are seemingly indepen-
dent of lipid composition as they are similar for both
DOPC and DOPC : PE : PG (4 : 3 : 1) lipid models.
Still, when investigated by NMR we find that the
effect of cholesterol on α-Syn is fundamentally differ-
ent for different lipid bilayers. In zwitterionic lipid
models (DOPC), it is the NAC region which is affected
the most by the presence of cholesterol, while in the
DOPC : PE : PG lipid model, it is the C-terminal and
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several N-terminal residues. The recently published
model of Viennet et al. [4] for α-Syn-lipid interaction
and fibrillation was able to rationalize fibrillation in
terms of lipid charge and fluidity; in this model, a pau-
city of high-affinity charged sites may lead to molecu-
lar crowding, where NAC segments are aligned at sites
in the liquid-ordered phase, resulting in accelerated
oligomerization. Relating our results to this model, we
propose that cholesterol-rich regions could act as such
nucleation sites. If sites with a net negative charge are
not available, cholesterol-rich sites will become the
next preferred site for binding and potential crowding.
Cholesterol, through its ordering effects on the mem-
brane, would make it harder for a polypeptide to
intercalate into the bilayer [12,86,87], leaving more
scope for protein–protein interaction at the water–lipid
interface. This difference in α-Syn binding behaviour
could be used to explain some discrepancy between
observed α-Syn interactions with cholesterol, primarily
by making a distinction between a cholesterol-rich,
NAC-supported binding mode and a high-charge,
high-fluidity mode supported primarily by the N-termi-
nal. Both modes can lead to increased fibrillation if
molecular crowding occurs at the available sites, but
cholesterol strongly promotes these events indepen-
dently of net charge. Given the high amount of choles-
terol in the synaptic membrane, this suggests that α-
Syn must neither overload potential nucleation sites
nor remain at such sites for an extended time. A possi-
ble interaction partner of α-Syn that might alleviate
such overload is the ubiquitous 14-3-3 proteins that
normally have roles as scaffolding proteins that bring
other proteins together. Several of the isoforms (seven
in humans) of this protein class have been identified in
Lewy bodies [88,89]. Interaction studies of the η-iso-
form and α-Syn showed that it binds to oligomeric but
not monomeric α-Syn, and intriguingly, this isoform is
also present in the synaptic membrane and synaptic
junctions [90]. In addition, the isoform was shown to
reduce α-Syn toxicity in cell models [91]. These obser-
vations suggest that 14-3-3 proteins may be involved
in handling α-Syn overload situations at cholesterol-
rich sites and may provide a link between the lipid
membrane and the proteostasis network.
Materials and methods
Recombinant α-Syn expression and purification
For use in this study, we modified the vector pET21a-al-
pha-synuclein (Addgene plasmid 51486) by introducing a
6x-histidine tag followed by a TEV cleavage site to the
N-terminal of α-Syn. This was achieved with the Q5®
Site-Directed Mutagenesis Kit (New England Biolabs,
Hitchkin, UK) using the primers listed in the Supplemen-
tary information (Table S3).
Unlabelled α-Syn was expressed and purified using a
variant of a previously described protocol [92]. The plasmid
encoding α-Syn was transformed into E. coli BL21 Star™
(DE3) (Invitrogen, Waltham, UK) following manufac-
turer’s instructions and plated onto lysogeny broth (LB)
agar plates supplemented with 100 µgmL−1 ampicillin. Sin-
gle colonies were used to inoculate 10 mL overnight starter
cultures. The following day, the overnight culture was used
to inoculate 1-litre cultures. All the cultures were grown in
media supplemented with 100 µgmL−1 ampicillin using
orbital shakers at 37 °C and 250 r.p.m. Protein expression
was induced when the cultures reached an optical density
of 0.4 (OD620) by the addition of IPTG to a final concen-
tration of 0.1 mM. Cells were harvested after 5 h by cen-
trifugation (10 000 g for 20 min). The obtained bacterial
pellets were resuspended in 20 mL osmotic shock buffer
(30 mM Tris/HCl [pH 8.0], 40% saccharose and 2 mM
EDTA) per gram cell wet weight before 10-min incubation
at room temperature. Following the osmotic shock, the
cells were collected by centrifugation (20 000 g for 20 min)
and the content of the periplasmic space was released by
adding 45 mL ice-cold water containing 1 mM MgCl2. Cell
debris was removed with centrifugation (20 000 g for
20 min). The supernatant containing α-Syn was mixed with
Na2HPO4 to a final concentration of 20 mM Na2HPO4 [pH
7.4] and supplemented with cOmplete™ EDTA-free pro-
tease inhibitors (Roche, Basel, Switzerland).
α-Syn was further purified with Ni-NTA affinity chro-
matography using a HisTrap HP 5-mL column (GE
Healthcare Life Sciences, USA) connected to an ÄKTA
system (GE Healthcare Life Sciences). The Ni-NTA purifi-
cation was performed using buffer A (20 mM Tris, 150 mM
NaCl and 20 mM imidazole [pH 8.0]) and buffer B (20 mM
Tris, 150 mM NaCl and 500 mM Imidazole [pH 8]). After
elution, the buffer was changed into TEV cleavage buffer
(20 mM Tris, 0.5 mM EDTA, 1 mM DTT and 150 mM NaCl
[pH 8.0]) using PD-10 columns (GE Healthcare Life
Sciences, Chicago, IL, USA).
The concentration of uncleaved α-Syn was determined
using an extinction coefficient at 280 nm of
7450 M−1cm−1. TEV (produced in-house according to van
den Berg et al. [93]) was added to α-Syn in a 1 : 100
molar ratio (TEV : α-Syn) and incubated for 16 h at 4 °C.
After the cleavage, α-Syn was collected by elution in
another Ni-NTA affinity chromatography step. Lastly, α-
Syn was purified by size-exclusion chromatography using
a HiLoad Superdex column 16/600 75 pg (GE Healthcare
Life Sciences) connected to an ÄKTA system (GE Health-
care Life Sciences). The concentration of purified α-Syn
was determined using an extinction coefficient at 280 nm
of 5960 M−1cm−1. Typical yield was 15 mg of cleaved pro-
tein per litre of medium.
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For isotopic labelling, we adapted a previously published
technique in which the culture is initially grown using LB
[94,95]. The culture was grown identically to the unlabelled
up to the point where the optical density reached 0.7. At
this point, the cells were harvested and resuspended into
M9 salt wash medium (25 mM KH2PO4, 10 mM NaCl,
5 mM MgSO4 and 0.2 mM CaCl2 [pH 8.0]). Following a
subsequent centrifugation (10 000 g for 20 min) step, the
cells were resuspended in modified Marley minimal medium
(25 mM KH2PO4 [pH 8.0], 10 mM NaCl, 5 mM MgSO4,
0.2 mM CaCl2, 1× trace metal solution according to Studier
[95], 0.25× vitamins (100× BME vitamin stock solution,
Sigma-Aldrich, Saint-Louis, MO, USA), 0.1% 15NH4Cl
and 1.0% glucose or 13C-glucose). The medium was added
in a 1 : 4 (v/v) ratio, that is, 250 mL of 4M media was
added for each 1 L of initial LB culture. The cultures were
further grown for 1 h at 37 °C. Expression was induced by
adding IPTG to a final concentration of 0.8 mM, and the
cells were grown for 5 h in orbital shakers at 37 °C and
250 r.p.m. Further purification was identical to the unla-
belled protein purification.
Preparation of Large unilamellar vesicles
LUVs were prepared using standard methods [96]. In brief,
lipid/cholesterol mixtures were prepared by dissolving
defined amounts of dried lipid powders (DOPC, DOPE,
DOPG and cholesterol from Avanti, USA) in 3 : 1 dichlor-
omethane : methanol mixtures followed by drying using
nitrogen gas and lastly in vacuo. The lipid films were
hydrated to 20 mM concentration of lipids by adding
50 mM Tris/HCl [pH 8.0]. The hydrated lipids were subse-
quently subjected to 4 rapid freeze–thaw cycles (−195 °C to
+60 °C) and extruded (13 passes) through a 100-nm poly-
carbonate filter (Mini-Extruder; Avanti Polar Lipids, Ala-
baster, Alabama, USA). The sizes of vesicles were
measured by dynamic laser light-scattering system (DLS)
using Zetasizer Nano ZS (Malvern Instruments, Malvern,
UK). The mean size of all vesicles was 100  6 nm with a
polydispersity index < 0.1.
Nanodisc preparation and characterization
SMA was prepared as described previously [97]. Briefly,
XIRAN SZ30010 (Polyscope, Geleen, the Netherlands) was
refluxed for 4 h in 5 % (w/v) in 1 M KOH. Once cool, 6 M
HCl was added dropwise to the solution at room tempera-
ture to a final concentration of 1.1 M, yielding a precipitate.
The precipitate was washed 3 times with 50 mL of 100 mM
HCl and then with 50 mL water. The precipitate was then
freeze-dried. The loss of the anhydride groups was demon-
strated by FTIR spectroscopy through the appearance of a
maleic acid carbonyl stretch at 1570 cm−1 and the loss of
the maleic anhydride carboxyl stretch at 1780 cm−1. The
polymer was stored as a solution of 8% (w/v) SMA in
50 mM Tris/HCl (pH 8.0) at −80 °C and was used without
further purification.
Nanodiscs were prepared using a modified procedure
based on Scheidelaar et al. [98] Hydrated lipids and SMA
were mixed in varying ratio based on nanodisc composi-
tion (see Table S1). The mixture was processed in the
same manner as hydrated lipids in LUV preparation (4
freeze-thawing cycles and 13 extrusion cycles through a
100-nm filter), and incubated overnight at room tempera-
ture. Nanodiscs were further purified by size-exclusion
chromatography using HiLoad Superdex column 16/600
200 pg (GE Healthcare Life Sciences) connected to an
ÄEKTA system. The fractions containing the desired nan-
odiscs were collected, and their size and zeta potential
were determined by DLS using (Nanosizer ZS Malvern
Instruments). The mean values of major nanodiscs peaks
are shown in Fig. 1A.
The lipid concentrations of the nanodiscs was deter-
mined by taking 100 μL of the purified nanodiscs, freeze-
drying them overnight (Alpha 1-2 LDplus, Christ, Osterode
am Harz, Germany), dissolving them in 300 μL of CUBO
solvent (800 μM guanidine chloride in mixture of dimethyl-
formamide (DMF) and trimethylamine (3 : 1); 20 % of
DMF was d-7 deuterated; Sigma-Aldrich) containing 50 μM
trimethyl phosphate standard (Sigma-Aldrich) and collect-
ing 31P NMR with AVANCE™ III HD 600 MHz NMR
instrument (Bruker Biospin AG, Fällanden, Switzerland).
Fluidity and packing of nanodiscs were explored by 6-do-
decanoyl-N,N-dimethyl-2-naphthylamine (Laurdan, Sigma-
Aldrich). Nanodiscs/vesicles (100 µM) and laurdan (1 µM)
were incubated at 37 °C, and fluorescence excitation and
emission were measured by PerkinElmer Fluorescence Reader
LS-55 (PerkinElmer, Waltham, MA, USA). Excitation and
emission spectra were measured with fixed wavelength—430
and 390 nm, respectively. Generalized polarizations plots
were calculated for temperatures 10, 20, 30 and 31 °C
(Fig. S2).
SPR assays
The SPR experiments were conducted in room temperature
using a T200 Biacore instrument (GE Healthcare) on an L1
chip. The surface of the L1 chip was conditioned with three
consecutive 1-minute injections of 20 mM CHAPS followed
by one injection of 30% ethanol. The flow rate for these
injections was 30 μLmin−1. Liposomes (10 mM in PBS)
were deposit in all cells for 40 min at a flow rate of
2 μLmin−1. The surface was stabilized by three injections
containing 100 mM NaOH for 1 min using a flow rate of
30 μLmin−1. The successful surface coverage was tested by
injecting 0.1 mgmL−1 of bovine serum albumin (BSA) for
1 min at 30 μLmin−1, and a change of < 400 RU indicated
sufficient coverage. Between experiments, the chip surface
was cleaned by subsequent injection of 20 mM CHAPS,
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40 mM octyl β-D-glucopyranoside and 30% ethanol, each
for 1 min at 30 μLmin−1.
For all measurement, the flow rate was fixed at
15 μLmin−1. Dilutions of α-Syn (from 8 μM to 0.063 μM, in
20 mM sodium phosphate [pH 6], 100 mM NaCl) were
injected over immobilized liposomes on the L1 chip. Injec-
tions were made from low to high concentration with 250-s
contact time and 400-s dissociation phase. Liposomes were
then regenerated by three subsequent injections of 100 mM
NaOH at 30 μLmin−1 for 1 min. The RU stability was
checked, and experiments were only executed if the RU
was in the range of  200 prior to the α-Syn injection. The
control flow cell was treated the same way as sample cells
(liposome coverage, stabilization, BSA coverage, regenera-
tion and cleaning) except that α-Syn injections were
replaced with buffer (20 mM sodium phosphate [pH 6] and
100 mM NaCl). Control flow cell background was sub-
tracted from the experimental cell before further data pro-
cessing. The data points for steady-state affinity analysis
were taken after 240-sec injection. The resulting curves
were fitted into Eqn (1) using in-laboratory written
MATLAB script (MATLAB R2017b).
Reg ¼ c∗Rmax
KDþ c þRoff: (1)
Steady-state SPR interaction fitting model where Reg =
response at equilibrium, c = concentration of α-Syn,
Rmax = maximum response, KD = dissociation constant
and Roff = response offset.
ThT and TPE-TPP assay
The aggregation experiments of α-Syn were performed at
37 °C using a FLUOstar Optima microplate fluorescence
reader (BMG LABTECH, Mölndal, Sweden) and moni-
tored by thioflavin T (ThT, Sigma-Aldrich) and TPE-TPP
(a kind gift from Ben Zhong Tang [35]) fluorescence. The
fluorescence was measured at time intervals of 600 s with
for 150 h. Before each measurement 3 mm orbital shaking
for 300 s was applied. The excitation and emission wave-
lengths were 430 (10) nm and 485 (5) nm for ThT and
360 (10) nm and 420 (10) nm for TPE-TPP. Lamp set-
tings were as follows: 10 flashes per well and 1300 gain
for ThT and 1900 gain for TPE-TPP. Experiments were
performed using black 384-well plate with clear bottom
(Corning, New York, NY, USA, Cat. N. 3762) sealed
with sealing tape (Thermo Fisher Scientific, Waltham,
MA, USA, Cat. N. 232701) to prevent evaporation. The
aggregation buffer contained 20 mM sodium phosphate
[pH 6], 100 mM NaCl, 10 mM NaN3 and 1 mM EDTA.
The final concentrations of the components in the wells
were 60 μM α-Syn, 5 μM ThT or TPE-TPP, and none or
1 mM of the lipid nanodiscs. Buffer and lipids alone were
also measured as controls. We performed three
independent experiments with 8–12 repeats for each sam-
ple. The recorded curves were processed using in-labora-
tory written MATLAB script (MATLAB R2017b). Similar
to the work of Aftiska et al. [52], cumulative curves were
recorded evaluating the percentage of wells having a sig-
nal three times higher than noise (mean of control wells
containing all the components except α-Syn). Each curve
was also fitted with Finke–Watzky two-step model Eqns
(2) and (3), and tn and ν were calculated [53].
F tð Þ¼ 1
1þ e4νðtt1=2Þ : (2)
tn ¼ t1=2 1
2ν
: (3)
The Finke–Watzky two-step model [53], where t1/2 is a
half time of fibrillation, ν is growth rate, and tN is lag time.
Atomic force microscopy
Samples for AFM analysis were prepared in the following
way. 2 µL of sample solution was deposited on a freshly
cleaved mica disc and left for 30 min in a closed Petri dish
(plastic, 50 mm in diameter). After deposition, 100 µL of
Milli-Q water (filtered and de-ionized 18.2 MΩcm at
25 °C) was added to each mica disc and incubated for one
minute with subsequent excess water removal by using
paper tissues. This procedure was applied three times, and
samples were left to dry in a closed Petri dish for two
hours. Sample morphologies were studied using a Bruker
Bioscope Catalyst Microscope in a Peak Force Quantitative
Nanomechanical Property Mapping mode. Silicon Nitride
Bruker ScanAsyst Air cantilevers with ~ 2-nm tip radius
and ~ 25° tip angle were used for imaging. Images were
taken at 256 × 256 px resolution. At least five images were
taken for each sample, which were at least 50 µm apart
from each other to ensure that the morphologies shown are
representative.
NMR spectroscopy
2D 1H-15N HSQC NMR spectra of 0.1 mM uniformly
labelled 15N α-Syn in 20 mM sodium phosphate [pH 6],
100 mM NaCl and 10% D2O were measured at 299 K
using 850 MHz (Bruker). We used best-HSQC
(b_hsqcetf3gpsi)94 and DOSY (stebpgls19) standard pulse
programmes supplied in TopSpin 4.0.1. Spectra were
recorded in the absence or presence of lipid nanodiscs at
500, 250, 125 or 62.5 μM total lipid concentration. Data
were processed using TopSpin, PINT [99] and in-labora-
tory written MATLAB scripts (MATLAB 2017b). Appar-
ent KD (aKD) calculations were done according to
Shortridge et al. [34], and the area of deconvoluted peaks
from PINT was used to calculate peak volume ratio
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B = 1 – (bound peak volume/free peak volume) and fitted






Protein–ligand binding model based on Shortridge et al.
[34] where B is the NMR volume ratio, VB the peak vol-
ume in bounded state, VF the peak volume in free state, c
the unitless NMR area ratio constant, [P]T the total protein
concentration, [L]T the total lipid concentration, aKD the
apparent dissociation constant and n the nonspecific bind-
ing constant.
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